Richard Bourgon

24.6k total citations · 3 hit papers
55 papers, 5.4k citations indexed

About

Richard Bourgon is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Richard Bourgon has authored 55 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 21 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Richard Bourgon's work include Cancer Genomics and Diagnostics (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Gene expression and cancer classification (7 papers). Richard Bourgon is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Gene expression and cancer classification (7 papers). Richard Bourgon collaborates with scholars based in United States, France and United Kingdom. Richard Bourgon's co-authors include Wolfgang Huber, Robert Gentleman, Zora Modrušan, Lars M. Steinmetz, Eugenio Mancera, Alessandro Brozzi, Tatyana G. Kahn, Vincenzo Pirrotta, Yuri B. Schwartz and Shannon J. Turley and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Richard Bourgon

54 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cross-tissue organization of the fibroblast lineage

2021 555 citations Zora Modrušan, Richard Bourgon et al. Nature profile →
Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy

2019 522 citations Claudia X. Dominguez, Sören Müller et al. Cancer Discovery profile →
Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer

2021 206 citations Mélanie Desbois, Shan Lu et al. Cancer Cell profile →

Peers

Countries citing papers authored by Richard Bourgon

Since Specialization

Citations

This map shows the geographic impact of Richard Bourgon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Bourgon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Bourgon more than expected).

Fields of papers citing papers by Richard Bourgon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Bourgon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Bourgon. The network helps show where Richard Bourgon may publish in the future.

Co-authorship network of co-authors of Richard Bourgon

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Bourgon. A scholar is included among the top collaborators of Richard Bourgon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Bourgon. Richard Bourgon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer 2022 ·Nature Communications ·Radia Marie Johnson, Xueping Qu, (unknown), Ling‐Yuh Huw, Avinashnarayan Venkatanarayan, Ethan Sokol, Fang‐Shu Ou, Nnamdi Ihuegbu, Oliver A. Zill, Omar Kabbarah, Lisa Wang, Richard Bourgon, Felipe de Sousa e Melo, (unknown), Anneleen Daemen, Alan P. Venook, Federico Innocenti, Heinz‐Josef Lenz, Carlos Bais	24
2	Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies 2021 ·Journal for ImmunoTherapy of Cancer ·(unknown), Andrew J. Wallace, (unknown), (unknown), (unknown), (unknown), Thomas D. Wu, Richard Bourgon, Ryan Jones, (unknown), Guang‐Yu Yang, Oliver A. Zill	10
3	Development of a gene expression–based prognostic signature for IDH wild-type glioblastoma 2020 ·Neuro-Oncology ·Radia Marie Johnson, Heidi Phillips, Carlos Bais, Cameron Brennan, Timothy F. Cloughesy, Anneleen Daemen, Ulrich Herrlinger, Robert B. Jenkins, Albert Lai, Christoph Mancao, Michael Weller, Wolfgang Wick, Richard Bourgon, Josep Garcia	19
4	Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer 2020 ·Nature Communications ·Mélanie Desbois, Akshata R. Udyavar, Lisa Ryner, Cleopatra Kozlowski, Yinghui Guan, Milena Dürrbaum, Shan Lu, Jean‐Philippe Fortin, Hartmut Koeppen, James Ziai, Ching‐Wei Chang, Shilpa Keerthivasan, Marie Plante, Richard Bourgon, Carlos Bais, Priti S. Hegde, Anneleen Daemen, Shannon J. Turley, Yulei Wang	139
5	Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy breakdown → 2019 ·Cancer Discovery ·Claudia X. Dominguez, Sören Müller, Shilpa Keerthivasan, Hartmut Koeppen, Jeffrey Hung, Sarah Gierke, (unknown), Oded Foreman, Travis W. Bainbridge, Alessandra Castiglioni, Yasin Şenbabaoğlu, Zora Modrušan, Yuxin Liang, Melissa R. Junttila, Christiaan Klijn, Richard Bourgon, Shannon J. Turley	522
6	Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast Cancers 2018 ·Molecular Cancer Research ·Timothy R. Wilson, Akshata R. Udyavar, Ching‐Wei Chang, Jill M. Spoerke, Junko Aimi, Heidi Savage, Anneleen Daemen, Joyce O’Shaughnessy, Richard Bourgon, Mark R. Lackner	15
7	High-Throughput and Sensitive Quantification of Circulating Tumor DNA by Microfluidic-Based Multiplex PCR and Next-Generation Sequencing 2017 ·Journal of Molecular Diagnostics ·Yinghui Guan, Oleg Mayba, Thomas Sandmann, Shan Lu, YounJeong Choi, Walter C. Darbonne, Vincent Lévêque, Lisa Ryner, Eric W. Humke, (unknown), (unknown), Anna Cheung, Richard Bourgon, Mark R. Lackner, Yulei Wang	18
8	Reactive stroma mediates CD8+ T cell spatial distribution and function in ovarian cancer 2017 ·Annals of Oncology ·(unknown), Lisa Ryner, Ameya Udyavar, Mélanie Desbois, Cleopatra Kozlowski, Chien‐Wen Chang, Yinghui Guan, Shan Lu, Hartmut Koeppen, James Ziai, Richard Bourgon, Priti S. Hegde	1
9	TGF-β signalling attenuates tumour response to PD-L1 checkpoint blockade by contributing to retention of T cells in the peritumoural stroma 2017 ·Annals of Oncology ·Sanjeev Mariathasan, Shannon J. Turley, Dorothee Nickles, Alessandra Castiglioni, Kobe Yuen, (unknown), (unknown), (unknown), Jillian L. Astarita, Rafael Cubas, Suchit Jhunjhunwala, Yanling Yang, Yasin Şenbabaoğlu, (unknown), Yohann Loriot, Ira Mellman, (unknown), Priti S. Hegde, Richard Bourgon, Tom Powles	8
10	Reproducible pharmacogenomic profiling of cancer cell line panels 2016 ·Nature ·Peter M. Haverty, Eva Lin, Jenille Tan, Yihong Yu, (unknown), Steve Lianoglou, Richard M. Neve, Scott E. Martin, Jeff Settleman, Robert L. Yauch, Richard Bourgon	185
11	Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial 2015 ·Journal of Clinical Oncology ·Thomas Sandmann, Richard Bourgon, Josep Garcia, Congfen Li, Timothy F. Cloughesy, Olivier Chinot, Wolfgang Wick, Ryo Nishikawa, Warren Mason, Roger Henriksson, Frank Saran, Albert Lai, N. Moore, Samir Kharbanda, Franklin Peale, Priti S. Hegde, Lauren E. Abrey, Heidi Phillips, Carlos Bais	208
12	Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma 2015 ·Cancer Cell ·Hayley J. Sharpe, Grégoire Pau, Gerrit J.P. Dijkgraaf, Nicole Basset‐Séguin, Zora Modrušan, Thomas Januario, Vickie Tsui, Alison B. Durham, Andrzej A. Dlugosz, Peter M. Haverty, Richard Bourgon, Jean Y. Tang, Kavita Y. Sarin, Luc Dirix, David C. Fisher, Charles M. Rudin, Howard Sofen, Michael R. Migden, Robert L. Yauch, Frédéric J. de Sauvage	296
13	High-Throughput Detection of Clinically Relevant Mutations in Archived Tumor Samples by Multiplexed PCR and Next-Generation Sequencing 2014 ·Clinical Cancer Research ·Richard Bourgon, Shan Lu, Yibing Yan, Mark R. Lackner, Weiru Wang, Victor Weigman, David Wang, Yinghui Guan, Lisa Ryner, Hartmut Koeppen, Rajesh Patel, Garret M. Hampton, Lukas C. Amler, Yulei Wang	52
14	Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes 2014 ·Cancer Research ·Genee Y. Lee, Peter M. Haverty, Li Li, Noelyn M. Kljavin, Richard Bourgon, James Lee, Howard M. Stern, Zora Modrušan, Somasekar Seshagiri, Zemin Zhang, (unknown), David Stokoe, Jeffrey Settleman, Frédéric J. de Sauvage, Richard M. Neve	125
15	Loss of NAPRT1 Expression by Tumor-Specific Promoter Methylation Provides a Novel Predictive Biomarker for NAMPT Inhibitors 2013 ·Clinical Cancer Research ·David S. Shames, Kristi Elkins, Kimberly Walter, Thomas Holcomb, Pan Du, Dane Mohl, Yang Xiao, (unknown), Peter M. Haverty, Bianca M. Liederer, Xiaorong Liang, Robert L. Yauch, Thomas O’Brien, Richard Bourgon, Hartmut Koeppen, Lisa D. Belmont	59
16	DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non–Small Cell Lung Cancer 2012 ·Clinical Cancer Research ·Walter Kim, Thomas Holcomb, Tom Januario, Pan Du, Marie Evangelista, (unknown), Leonardo Iniguez, Robert Soriano, Ling Huw, Howard M. Stern, Zora Modrušan, Somasekar Seshagiri, Garret M. Hampton, Lukas C. Amler, Richard Bourgon, Robert L. Yauch, David S. Shames	66
17	Querying Genomic Databases: Refining the Connectivity Map 2012 ·Statistical Applications in Genetics and Molecular Biology ·Mark R. Segal, Hao Xiong, Henrik Bengtsson, Richard Bourgon, Robert Gentleman	12
18	Alternative Epigenetic Chromatin States of Polycomb Target Genes 2010 ·PLoS Genetics ·Yuri B. Schwartz, Tatyana G. Kahn, Per Stenberg, Katsuhito Ohno, Richard Bourgon, Vincenzo Pirrotta	161
19	High-resolution mapping of meiotic crossovers and non-crossovers in yeast 2008 ·Nature ·Eugenio Mancera, Richard Bourgon, Alessandro Brozzi, Wolfgang Huber, Lars M. Steinmetz	470
20	The Serine Repeat Antigen (SERA) Gene Family Phylogeny in Plasmodium: The Impact of GC Content and Reconciliation of Gene and Species Trees 2004 ·Molecular Biology and Evolution ·Richard Bourgon, Mauro Delorenzi, (unknown), Anthony N. Hodder, Brendan S. Crabb, Terence P. Speed	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact